60 DEGREES PHARMACEUTICALS, INC. (SXTP) Return on equity 2023–2025
60 DEGREES PHARMACEUTICALS, INC. (SXTP) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-212.7%FY2025 · since FY2023: -77.3% → -212.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -212.7% | -15.7 pp |
| FY2024 | -196.9% | -119.6 pp |
| FY2023 | -77.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice